319 related articles for article (PubMed ID: 20829529)
41. MR imaging of ampullary carcinomas.
Irie H; Honda H; Shinozaki K; Yoshimitsu K; Aibe H; Nishie A; Nakayama T; Masuda K
J Comput Assist Tomogr; 2002; 26(5):711-7. PubMed ID: 12439303
[TBL] [Abstract][Full Text] [Related]
42. Expression of MUC1 and MUC2 in ampullary cancer.
Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
[TBL] [Abstract][Full Text] [Related]
43. Approaches to Biopsy and Resection Specimens from the Ampulla.
Xue Y; Reid MD
Surg Pathol Clin; 2020 Sep; 13(3):453-467. PubMed ID: 32773194
[TBL] [Abstract][Full Text] [Related]
44. Imaging for the diagnosis and staging of periampullary carcinomas.
Walsh RM; Connelly M; Baker M
Surg Endosc; 2003 Oct; 17(10):1514-20. PubMed ID: 12915975
[TBL] [Abstract][Full Text] [Related]
45. Assessment of physiologic bile flow in the extrahepatic bile duct with cine-dynamic MR cholangiopancreatography and a spatially selective inversion-recovery pulse.
Ito K; Kanki A; Yamamoto A; Tamada T; Yasokawa K; Tanimoto D; Sato T; Higaki A; Noda Y; Yoshida K
Radiology; 2014 Mar; 270(3):777-83. PubMed ID: 24475829
[TBL] [Abstract][Full Text] [Related]
46. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
47. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
[TBL] [Abstract][Full Text] [Related]
48. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V
J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668
[TBL] [Abstract][Full Text] [Related]
50. Comparison between the location and the histomorphological/immunohistochemical characteristics of noninvasive neoplasms of the ampulla of Vater.
Yamamoto Y; Nemoto T; Okubo Y; Nihonyanagi Y; Ishiwatari T; Takuma K; Tochigi N; Okano N; Wakayama M; Igarashi Y; Shibuya K
Hum Pathol; 2014 Sep; 45(9):1910-7. PubMed ID: 25081540
[TBL] [Abstract][Full Text] [Related]
51. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Jang JY; Kim SW; Kang GH; Yoon YB
Ann Surg Oncol; 2007 Nov; 14(11):3195-201. PubMed ID: 17710498
[TBL] [Abstract][Full Text] [Related]
52. Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.
Sung JY; Kim GY; Lim SJ; Park YK; Kim YW
Pathol Res Pract; 2010 Jan; 206(1):24-9. PubMed ID: 19819644
[TBL] [Abstract][Full Text] [Related]
53. Ampullary carcinoma: demonstration by current MR techniques.
Semelka RC; Kelekis NL; John G; Ascher SM; Burdeny D; Siegelman ES
J Magn Reson Imaging; 1997; 7(1):153-6. PubMed ID: 9039607
[TBL] [Abstract][Full Text] [Related]
54. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
[TBL] [Abstract][Full Text] [Related]
55. Multiparameter digital image analysis of biliary, ampullary, and pancreatic adenocarcinomas.
Yeaton P; Kiss R; DePrez C; Salmon I; Pasteels JL; Jones RS; Frierson HF
Mod Pathol; 1995 Oct; 8(8):843-7. PubMed ID: 8552573
[TBL] [Abstract][Full Text] [Related]
56. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
57. [Pathogenesis and histomorphology of ampullary carcinomas and their precursor lesions. Review and individual findings].
Fischer HP; Zhou H
Pathologe; 2003 May; 24(3):196-203. PubMed ID: 12739053
[TBL] [Abstract][Full Text] [Related]
58. Pathogenesis of carcinoma of the papilla of Vater.
Fischer HP; Zhou H
J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428
[TBL] [Abstract][Full Text] [Related]
59. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
[TBL] [Abstract][Full Text] [Related]
60. Differentiation of infiltrative cholangiocarcinoma from benign common bile duct stricture using three-dimensional dynamic contrast-enhanced MRI with MRCP.
Yu XR; Huang WY; Zhang BY; Li HQ; Geng DY
Clin Radiol; 2014 Jun; 69(6):567-73. PubMed ID: 24581958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
